OLLIE integrates with Pleio's GoodStart program and supports pharmaceutical companies in earlier identification and understanding of patient sentiment and confidence...
Presidential lecture to be delivered by Robert Langer at Rice followed by RBL LLC launch event with keynote presentation by Robert...
MINNEAPOLIS, March 26, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre...
NEW YORK and PARIS, March 26, 2025 /PRNewswire/ -- Rarecells Inc., a pioneering company in liquid biopsy technology, is pleased...
Integration of AI-Driven Prior Authorization, Cost Estimates, and Scheduling into RamSoft's RIS to Streamline Front-Office Operations NASHVILLE, Tenn., March 26, 2025...
COLOGNE, Germany, March 26, 2025 /PRNewswire/ -- SprintRay, a global leader in digital dentistry solutions, will debut new expansions to its...
U.S. ranks first in European patent applications, followed by Germany, Japan, China, and Republic of Korea European Patent Office (EPO) received...
HONOLULU, March 26, 2025 /PRNewswire/ -- Pediatric Dentistry Kahala is thrilled to introduce its new website at https://www.pediatricdentistrykahala.com. The updated website...
New tools will calculate the ROI of using digital endpoints in clinical trials, empowering greater innovation in research BOSTON, March...
Los Angeles, CA, March 26, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company"), a medical technology...
"Trailblazing Physician and Advocate Receives U.S. Congressional Award for Advancing Healthcare Access and Community Service Across Central Florida and Beyond"...
MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for...
CORAL GABLES, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, or “the Company”), a clinical-stage...
Oslo, Norway, 26 March, 2025 Reference is made to the stock exchange notice published by Zelluna ASA (the "Company") published...
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc....
AZURE-1 will evaluate the efficacy and safety of brelovitug compared to delayed treatmentREDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE)...
Houston, TX, March 26, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) is pleased...
Company’s 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company’s competitive...
ST. PETERSBURG, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- In today's fast-paced world, guts and skin health has become a...
Oslo, Norway, 26 March, 2025 Reference is made to the stock exchange notice published on 9 January 2025 regarding an...